Eyevance gets US rights to Nicox's Zerviate
Nicox Ophthalmics Inc. licensed Eyevance Pharmaceuticals LLC rights to commercialize its Zerviate (cetirizine) ophthalmic solution 0.24% in the US.
- Topical Delivery
- Drug Delivery
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com